Analyst
Maxim Group
Equibles does not estimate personal net worth.
Michael Okunowich is recorded as Analyst at Maxim Group. Michael Okunowich has spoken on 5 earnings calls across 4 companies, most recently for Longeveron Inc. on August 12, 2026. Those appearances were for Co-Diagnostics, Inc. (CODX), Longeveron Inc. (LGVN), Bionano Genomics, Inc. (BNGO) and MediWound Ltd. (MDWD). The companies whose calls Michael Okunowich spoke on are classified in the Healthcare sector.
“I just wanted to ask a little bit about how you're going to be collecting the events-based data, because it's only a 12-month endpoint for RVEF. So is this something that you're expecting to collect over time and we're planning to do as part of some longer-term follow-up?”
“So I guess just to start things off, I wanted to see if any of the growth you've seen in consumables, unit-placed shipments, or in terms of revenue, has been driven by the new pricing on the CPT code in hematology, or if we're still expecting that to take some more time to materialize.”
“I think to start off, I'd like to ask a little bit about the consensus document published in wounds.”
“And it looks like there's a lot of exciting stuff going on, great progress. I guess to start off, my question lies around scalability and your scale-up plan. Since these are pretty big markets and you're approaching them fast, what's your current capacity for producing the test kits?”
“Thank you for taking my questions and congrats on the speedy resolution of the listing challenges. Good to see you back on the NASDAQ.”
Maxim Group
Analyst
Transcript header (unverified)
CODX
Medical Devices · Healthcare
LGVN
Biotechnology · Healthcare
Medical Instruments & Supplies · Healthcare
MDWD
Biotechnology · Healthcare
